Rubius Therapeutics Garners $25,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=46c3f673-ad78-4d21-8374-d4018b255015 - Date
12/10/2015 - Company Name
Rubius Therapeutics - Mailing Address
620 Memorial Drive Cambridge, MA 02139 USA - Company Description
Rubius is developing a new class of drugs, Red-Cell Therapeutics, for the treatment of a wide array of diseases. - Website
http://www.rubiustx.com - Transaction Type
Venture Equity - Transaction Amount
$25,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds will enable Rubius to enter clinical testing of its novel therapeutic modality. - M&A Terms
- Venture Investor
Flagship Ventures
